Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
Crossref DOI link: https://doi.org/10.1007/s12094-024-03442-3
Published Online: 2024-04-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Yanqing http://orcid.org/0009-0009-5840-5143
Chen, Wei
Dong, Lixian
Duan, Lian
Gao, Pengfei
Text and Data Mining valid from 2024-04-16
Version of Record valid from 2024-04-16
Article History
Received: 14 January 2024
Accepted: 4 March 2024
First Online: 16 April 2024
Declarations
:
: The authors have declared that no conflict interest exists.